SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY

OHare Meghan; Griewe Richard; Broecker Katherine; Al-Sayegh Hasan; Ma Clement; Fishman Steven; Adams Denise; Trenor Cameron

首页> 外文期刊>Pediatric blood & cancer >SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY

【24h】

SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY

机译：Sirolimus在120例血管异常患者中的安全性和患者报告的疗效：淋巴异常登记处的报告

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2018年第1期|共1页
作者
OHare Meghan; Griewe Richard; Broecker Katherine; Al-Sayegh Hasan; Ma Clement; Fishman Steven; Adams Denise; Trenor Cameron;
展开▼
作者单位

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

Boston Childrens Hosp Boston MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY [J] . OHare Meghan, Griewe Richard, Broecker Katherine, Pediatric blood & cancer . 2018,第Suppla1期

机译：Sirolimus在120例血管异常患者中的安全性和患者报告的疗效：淋巴异常登记处的报告
2. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA) [J] . Michio Ozeki, Ryuta Asada, Akiko M. Saito, Regenerative Therapy . 2019,第2期

机译：西罗莫司治疗顽固性淋巴异常的疗效和安全性：开放标签，单臂，多中心，前瞻性研究（SILA）的研究方案
3. UNDERSTANDING THE IMMUNE STATUS OF PATIENTS WITH NON-COMPLICATED VASCULAR OR LYMPHATIC ANOMALIES TREATED WITH SIROLIMUS [J] . Fernandez Karen, Setty Bhuvana, Shimano Kristin, Pediatric blood & cancer . 2018,第Suppla1期

机译：了解用西罗司处理的非复杂血管或淋巴异常患者的免疫状态
4. Applying the FAIR Data Principles to the Registry of Vascular Anomalies (VASCA) [C] . Bruna DOS SANTOS VIEIRA, Karlijn GROENEN, P.A.C. ‘T HOEN, Health Informatics Meets Digital Healtd Conference . 2020

机译：将公平数据原则应用于血管异常的注册表（Vasca）
5. Assessment of Health-Related Quality of Life, Patient-Reported Mental Health Status and Psychological Distress based on the Type of Pharmacotherapy used Among Patients with Depression. [D] . Shah, Drishti. 2015

机译：根据抑郁症患者使用的药物治疗类型，评估与健康有关的生活质量，患者报告的心理健康状况和心理困扰。
6. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label single-arm multicenter prospective study (SILA) [O] . Michio Ozeki, Ryuta Asada, Akiko M. Saito, 2019

机译：西罗莫司治疗顽固性淋巴异常的疗效和安全性：开放标签单臂多中心前瞻性研究（SILA）的研究方案
7. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review [O] . Cristiana Freixo, Vítor Ferreira, Joana Martins, 2020

机译：西罗莫司治疗血管异常治疗的疗效和安全性：系统审查

SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY

著录项

相似文献

相关主题

期刊订阅